Evaluation of serum procalcitonin level as a biomarker for disease severity in COVID-19 patients

The pandemic of coronavirus disease 2019 (COVID-19) has infected millions of individuals around the globe. Forecasting the COVID-19 severity is essential, and various biomarkers could be used to evaluate it. The current study was therefore aimed to evaluate the serum pro-calcitonin (PCT) level as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Waris, A., Din, M., Iqbal, N., Yar, L., Khalid, A., Nawaz, M., Baset, A., Ali, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302477/
https://www.ncbi.nlm.nih.gov/pubmed/34336223
http://dx.doi.org/10.1016/j.nmni.2021.100922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302477/
https://www.ncbi.nlm.nih.gov/pubmed/34336223
http://dx.doi.org/10.1016/j.nmni.2021.100922

Ejemplares similares